# Shanghai Dunfu Medical Management Group Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-dunfu-medical-management-group-co

- Industry: Healthcare
- Headquarters: Shanghai, China
- Website: www.denfogroup.com
- Total disclosed funding: $16M
- Latest round: Series A (Feb 25, 2022)
- Investors on record: 2

## About

Established in 2012 and based in Shanghai, China, Shanghai Dunfu Medical Management Group Co., Ltd. is a tumor diagnosis and treatment medical platform. The company focuses on tumor treatment. It has established offline chain tumor hospitals, online management platform for tumor patients, and cooperation in tumor drug research. In May 2018, this company's first medical facility, Shanghai Dunfu Hospital, was officially opened. In February 2022, the company raised at least CNY 100 million in series A funding from new investor.

The company's main business is oncology ecosystem businesses such as self-built and operated oncology specialist chain hospitals, multi-disease management of oncology, and tumor data operation. Besides, the company provides cancer testing and patient redirection service, application of new cancer drugs and AE management service, perioperative support services, cancer rehabilitation service, disease management of specific cancer service, and research support and digital cancer care service.

## Funding rounds

- Series A, Feb 25, 2022, $16M — New Frontier, Smartgain Capital

## Investors

- New Frontier (https://capitalatlas.ai/funds/new-frontier) — Series A
- Smartgain Capital (https://capitalatlas.ai/funds/smartgain-capital) — Series A